SCHEMBL627112

SCHEMBL627112

CN(c1nn2cc(I)nc2s1)C1CCC(=O)CC1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 1/20 0.34
PI4KB Q9UBF8 1/20 0.30
MPO P05164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623859 0.83 F2RL3 (0.34) F2RL3
SCHEMBL624133 0.81 RORC (0.34)
SCHEMBL625010 0.80 HSD11B1 (0.35) F2RL3
SCHEMBL625051 0.72 MAP3K12 (0.46)
SCHEMBL2250793 0.64 DYRK1A (0.32)
SCHEMBL2257063 0.64 LRRK2 (0.31)
SCHEMBL28944696 0.60 ALPL (0.32)
SCHEMBL2257064 0.59 MKNK1 (0.44) F2RL3PI4KB
SCHEMBL625009 0.58 HSD11B1 (0.31)
SCHEMBL626842 0.58 FYN (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed